Carlyle Group Inc.Carlyle Group Inc.

Institutional investor · Portfolio as of Q1 2023

Top Holdings30 positions

Checking export access…
Activity:

Quidelortho Corp

12.5M$1.1B33.1%$97.18-8.32%
4 qtrssince 2022-Q2
Unchanged
0

ZOOMINFO TECHNOLOGIES INC

36.7M$905.9M27.0%$50.72-51.85%
12 qtrssince 2020-Q2
Unchanged
0

MKS INC.

8.5M$751.7M22.4%$82.62+3.37%
3 qtrssince 2022-Q3
Unchanged
0
VTRUVTRUDelisted

VITRU LTD

6.2M$142.2M4.2%——
11 qtrssince 2020-Q3
Unchanged
0
GDSGDS
ADR

GDS HLDGS LTD

4.1M$76M2.3%$20.58-2.70%
2 qtrssince 2022-Q4
Increased
56

VAXCYTE INC

1.9M$72.1M2.2%$36.27+75.41%as of Oct 16
1 qtr
New
78

GETTY IMAGES HOLDINGS INC

11.9M$60.6M1.8%$5.55-8.11%
2 qtrssince 2022-Q4
Unchanged
0
VRNAVRNADelisted
ADR

VERONA PHARMA PLC

2.5M$49.3M1.5%——
1 qtr
New
68
HLVXHLVXDelisted

HILLEVAX INC

1.8M$30.1M0.9%——
1 qtr
New
57

VERA THERAPEUTICS INC

3M$22.9M0.7%$7.440.00%
1 qtr
New
57

PHATHOM PHARMACEUTICALS INC

2.9M$20.9M0.6%$6.800.00%
1 qtr
New
56

JASPER THERAPEUTICS INC

8.8M$15.8M0.5%$18.800.00%
1 qtr
New
48
INVHINVH
REIT

INVITATION HOMES INC

477,500$14.9M0.4%$27.250.00%
1 qtr
New
48
2.1M$12.2M0.4%——
1 qtr
New
47
2.1M$12.2M0.4%——
1 qtr
New
47
LSILSIDelisted
REIT

LIFE STORAGE INC

86,000$11.3M0.3%——
3 qtrssince 2022-Q3
Unchanged
0
CUBECUBE
REIT

CUBESMART

220,500$10.2M0.3%$32.92+18.04%
3 qtrssince 2022-Q3
Unchanged
0

SEACOR MARINE HOLDINGS INC

1.3M$10M0.3%$10.73-31.42%
18 qtrssince 2018-Q4
Increased
37

SPRUCE BIOSCIENCES INC

2.9M$6.4M0.2%$12,318.750.00%
1 qtr
New
46
EMEMDelisted
ADR

SMART SH GLOBAL LTD

4.8M$5.3M0.2%——
4 qtrssince 2022-Q2
Unchanged
0
$3.4B
AUM
30
Positions
Q1 2023
Filing
HI score · 1.5/5
Quarterly 13F Value Change
-17%Q3'20$7.3B+80%Q1'21$13.2B-76%Q3'22$3.1B+9%Q4'22$3.4B-2%Q1'23$3.4B
Activity profile
$ moved · Q1'23
New54%Increased1%Decreased0%Exited46%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.8 quarters
<1Q63%1-4Q27%1-2Y0%2Y+10%

Carlyle Group Inc. manages $3.4B across 30 positions as of Q1 2023. Top holdings: QDEL (33.1%), GTM (27.0%), MKSI (22.4%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1.5/5.0.

Q1 2023 Summary

Active quarter - 19 new positions, 2 exits, 2 increased. Top move: PCVX (NEW, conviction 78). Portfolio: $3.4B across 30 positions.

Top holdings by portfolio weight

Total AUM$3B
QDEL33.11%
GTM27.02%
MKSI22.43%
VTRU4.24%
GDS2.27%
PCVX2.15%
GETY1.81%
VRNA1.47%
HLVX0.90%
VERA0.68%
Other0.62%

Portfolio allocation by GICS sector

Sectors7
Technology51.77%
Healthcare37.40%
Unknown7.81%
Communication Services1.81%
Real Estate0.75%
Industrials0.30%
Consumer Cyclical0.16%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Technology, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L12
Conviction38
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used